Actively Recruiting
PEDI Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcus Study
Led by University of Wisconsin, Madison · Updated on 2026-01-27
30
Participants Needed
2
Research Sites
145 weeks
Total Duration
On this page
Sponsors
U
University of Wisconsin, Madison
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The objective of the Pediatric Epidemiological Data and Incidence (PEDI) PANDAS study is to demonstrate the feasibility of enrollment and retention of subjects in a study to determine the incidence and natural history of children with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) with regard to spectrum, course and outcome. The investigators aim to demonstrate they can recruit and retain 85% of children who are eligible for this study. Eligible children are those who fit criteria for PANS and Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcus (PANDAS). Each child will be followed for one year.
CONDITIONS
Official Title
PEDI Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcus Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Child age 3 to 17 years old
- Child and parent/guardian able to complete all study activities in English
- Family plans to be followed within UW Health or Dartmouth Health for at least one year
- Pediatric patient currently in primary care at UW Health or Dartmouth Health (primary care group only)
- Abrupt onset of symptoms within 7 days, occurring in the past 3 months (primary care group only)
- Suspected diagnosis of PANS or PANDAS based on published criteria (primary care group only)
- Abrupt onset of symptoms within 7 days, occurring in the past 4 months (external to primary care group only)
- Confirmed diagnosis of PANS or PANDAS based on published criteria (external to primary care group only)
You will not qualify if you...
- History of tics, OCD, or food restriction/avoidance inconsistent with sudden onset or present before investigation onset
- Current symptoms of Pica
- Previous participation in this study
- Not suitable for study participation as judged by the site investigator (e.g., insufficient verbal or cognitive ability)
- Patient or family unable to complete study questionnaires or procedures in English as primary language
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03766
Actively Recruiting
2
UW School of Medicine and Public Health
Madison, Wisconsin, United States, 53792
Actively Recruiting
Research Team
P
Pediatric Clinical Research Coordination
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here